Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Navigating the crypto market is easier with user-friendly investment approaches. This guide provides strategies designed for beginners.
21,210 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...
Looking to build retirement wealth with a focus on AI? This guide highlights three AI stocks worth holding until reti...
Top five holdings make up about 37% of QQQ’s assets, with NVIDIA alone near 10%. As AI-driven spending shapes markets...
When a legendary filmmaker hints at retirement at 96, investors and families should pay attention to how wealth, roya...
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
A 17% drop in NUGT on Friday highlights the peril of 2x leverage in mining ETFs as gold prices retreat and larger min...
Two very different computer vision players sit at automation's frontier. This guide weighs Aeva Technologies and Cogn...
Futures contracts are the hidden engine of price discovery across oil, stocks, and gold. Amid elevated tensions and v...
Three international dividend ETFs are delivering notably higher yields than SCHD in mid-2026, driven by cheaper overs...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
June data show housing demand holds steady across regions despite mortgage rates near 6.6%. Regional inventory shifts...